GlaxoSmithKline plc (GSK) Rating Reiterated by J P Morgan Chase & Co

GlaxoSmithKline plc (GSK) Rating Reiterated by J P Morgan Chase & Co


's stock had its "neutral" rating restated by J P Morgan Chase & Co in a research note issued on Monday. They currently have a GBX 1,470 price target on the stock.



from Biotech News